CAP 150 Pill - pink capsule/oblong, 11mm
Pill with imprint CAP 150 is Pink, Capsule/Oblong and has been identified as Capecitabine 150 mg. It is supplied by Shilpa Medicare Limited.
Capecitabine is used in the treatment of Colorectal Cancer; Breast Cancer, Metastatic; Pancreatic Cancer; Stomach Cancer; Breast Cancer and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CAP 150
Capecitabine
- Imprint
- CAP 150
- Strength
- 150 mg
- Color
- Pink
- Size
- 11.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Shilpa Medicare Limited
- National Drug Code (NDC)
- 63759-3000
- Inactive Ingredients
-
lactose anhydrous,
croscarmellose sodium,
hypromelloses,
microcrystalline cellulose,
magnesium stearate,
water,
titanium dioxide,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
See also:
More about capecitabine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (65)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimetabolites
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.